1. Home
  2. CSBR vs CLST Comparison

CSBR vs CLST Comparison

Compare CSBR & CLST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Champions Oncology Inc.

CSBR

Champions Oncology Inc.

HOLD

Current Price

$5.17

Market Cap

81.0M

Sector

Health Care

ML Signal

HOLD

Logo Catalyst Bancorp Inc.

CLST

Catalyst Bancorp Inc.

HOLD

Current Price

$16.89

Market Cap

67.3M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSBR
CLST
Founded
1985
1922
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
81.0M
67.3M
IPO Year
2015
2021

Fundamental Metrics

Financial Performance
Metric
CSBR
CLST
Price
$5.17
$16.89
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
8.3K
2.1K
Earning Date
03-12-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
171.79
EPS
N/A
0.15
Revenue
$2,900,000.00
N/A
Revenue This Year
$4.84
N/A
Revenue Next Year
$11.51
N/A
P/E Ratio
N/A
$113.00
Revenue Growth
N/A
N/A
52 Week Low
$5.15
$12.51
52 Week High
$8.74
$18.16

Technical Indicators

Market Signals
Indicator
CSBR
CLST
Relative Strength Index (RSI) 37.31 53.74
Support Level N/A $16.24
Resistance Level $6.31 $17.19
Average True Range (ATR) 0.29 0.24
MACD -0.06 -0.02
Stochastic Oscillator 3.01 42.71

Price Performance

Historical Comparison
CSBR
CLST

About CSBR Champions Oncology Inc.

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.

About CLST Catalyst Bancorp Inc.

Catalyst Bancorp Inc is a bank holding company. Through its subsidiary, which is a federally chartered community-oriented savings bank, it is engaged in attracting deposits from the general public and using those funds to invest in loans and securities. The sources of funds are customer deposits, repayments of loans, maturities of investments, and funds borrowed from outside sources, which are used for the origination of loans. It operates in one reportable segment, which generates income principally from interest on loans and investment securities, as well as from fees charged in connection with various loan and deposit services.

Share on Social Networks: